2cureX advances towards IVD-R compliance by securing a contr

2cureX advances towards IVD-R compliance by securing a contract with a Notified Body2cureX, a company pioneering the use of 3D tumoroids for drug sensitivity prediction in patients with cancer, announced today the signature of a contract with a Notified Body under Regulation (EU) 2017/746 on in vitro diagnostic medi...

Related Keywords

Stockholm , Sweden , Emanuel Martin , Fernando Andreu , Regulatory Affairs , Medtech Europe The European Medical Technology , Notified Body , Conformity Assessment , Notified Bodies , Medical Devices , European Directives , Technical Files , Quality Management Systems , European Medical Technology , Quality Assurance , Person Responsible , Regulatory Compliance , Quality Management System , Chief Executive , Individual Treatment , Vitro Diagnostic , Precision Oncology , Nasdaq First North Growth Market ,